Respiratory Inhalers Market Synopsis:
Respiratory Inhalers Market Size Was Valued at USD 34.2 Billion in 2023, and is Projected to Reach USD 57.32 Billion by 2032, Growing at a CAGR of 5.9% From 2024-2032.
The respiratory inhalers market concerns product categories designed to deliver symptomatic remedies to the lungs for treatment of respiratory conditions more specifically; asthma, COPD, and other respiratory illness. Notably, these devices can be categorized into those which are manually controlled, and those which are digitally controlled; in optimizing the delivery of medication, the difference lies in how these two classes of devices are achieved control.
The respiratory inhalers market has showcased substantial upswing in the last few years as respiratory ailments are devouring, along with focused prevision on preventive care. Asthma and Chronic Obstructive Pulmonary Disease are the most prevalent diseases that require inhalation therapy for millions of patients. The subject matter of inhaler therapy has benefited from advances in technology, so efficiency is significantly increased, and compliance with the prescribed treatment regimen is improved. As the cases of the growing population of people who are aging and environmental pollution continue to rise, there is the increased need for inhalation therapy.
The current COVID-19 pandemic has also affected the respiratory inhaler market since people have been forced to pay attention on their respiratory tracts by seeking effective medications. Drug delivery system manufacturers are focused on developing new designs of inhalation devices that include connectivity with smart technology to enable analysis of patient data. With the advancement of technology most aspects of care, including respiratory care, have developed digitally operated inhalers that can monitor usage and notify the patients and doctors. It is believed that these enhancements will lead to an expansion of the market and enhanced attempts at treating respiratory illnesses.
Respiratory Inhalers Market Trend Analysis:
Increased Adoption of Smart Inhalers
- That how the trend of adopting smart inhalers has emerged as a major driving force in the respiratory inhalers market. The latest smart inhalers have integrated sensors that capture data about medication use, which can be used to encourage patients and doctors to adjust a treatment regimen. It often provides connection to mobile application where users get reminder and alerts for better management of respiratory diseases. The adoption of digital health technologies also fosters compliance and at the same time patients may use the data to manage disease better.
- Since more people prefer individual approaches and treatments, there is apt to be a growing trend towards the smart inhalers. Clinicians are also beginning to understand these devices as a way to enhance patient care by providing more accurate measurements with which to monitor and adjust treatment plans. This is backed by current innovation of technologies, and the rise of patient-centricity making the adoption and ensconce of smart inhalers as part of the conventional respiratory care systems possible.
Expansion in Emerging Markets
- The resectable market pertaining to respiratory inhalers is likely to emerge significantly in new markets. With the economic development of these areas the issue of illnesses affecting the respiratory system, and the need for proper treatment becomes more and more recognized. Authorities of emerging economy countries are also investing on the healthcare facilities, thus making it easier in the management of respiratory illness among patients. It has become a popular trend creating a good market play where all the market players can establish themselves in those new virgin markets.
- Due to the rising incidence of asthma and COPD, especially in nascent economies, which is attributable to factors such as urbanization and pollution, create a chance for manufacturing companies to develop and market affordable and effective inhalation drugs. Through changes of some features of their products to suits the local peoples needs and spending money in campaigns that inform the people on the importance of taking good care of their respiratory system through education Ads the companies stand a better chance to benefit from the larger market of people and also help in increasing the health standards of people.
Respiratory Inhalers Market Segment Analysis:
Respiratory Inhalers Market is Segmented on the basis of Type, Product, Application, End User, and Region.
By Type, Manually Operated segment is expected to dominate the market during the forecast period
- The respiratory inhalers market can therefore be divided into manually operated inhalers and digitally operated inhalers. MDIs and DPIs have been commonly used for delivering medication to patients with ASTHMA as manually operated inhalers. These devices rely on the patient for proper synchronization of the motion of the canister with their inhaling abilities, which in most cases results in poor usage and delivery of the drug. And yet their continued availability on the market and their relative affordability still makes them a choice fix.
- While continuous flowline inhalers remain in use, digitally operated inhalers are on the rise because of added attributes that promote patients’ compliance. These inhalers tend to include sensors and, or connectivity to mobile applications and this helps in monitoring usage as well as giving feedback to the patient and other relevant health care givers. Considering trends of the healthcare industry that is becoming more reliant on data, digitally operated inhalers will only gain in popularity and change the approach to respiratory diseases management.
By Application, Asthma segment expected to held the largest share
- The market can be divided by application such as asthma, COPD, arterial hypertension and other respiratory diseases. Asthma is probably one of the most frequent uses of inhalers since it is a widespread disease that demands consistent treatment all around the globe. Increased knowledge of itself as asthma and the need to adhere to inhalation therapy positively influences the development of inhalers for AFL patients with asthma.
- Another growing area for this market is chronic obstructive pulmonary disease (COPD). Since COPD prevalence increases due to causes like smoking and toxic emissions, the need for efficient inhalation treatment grows. To help COPD patients, especially those with an advanced stage of the disease, manufacturers are designing new-generation inhalers. Understanding the importance of having treatment plans specific to different respiratory diseases is leading to new innovations and growing the respiratory inhalers market.
Respiratory Inhalers Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
- North America is the largest market for respiratory inhalers, due to the availability of advanced healthcare facilities, high HC expenditure and high incidences of respiratory disorders. Healthcare’s evolution in the region makes it easy for many people to embrace new innovations in inhalation technologies so that patients can access the best treatment possible. Moreover, the largest share of the market holds leading players in North America and this region exhibits constant improvement of the inhaler devices that improves the rates in the patietents and augments the demand of inhalation therapies.
- General health consciousness of the respiratory diseases and demanding order on the professional medical and patient prescription and compliance prescriptions in North America has also driven the dominance of this market. Therefore, it can be stated that the market for respiratory inhalers in the region will continue to develop at a high pace due to the constant innovation, friendly regulation policies, and growing attention to enhance the quality of life of patient suffering with respiratory diseases.
Active Key Players in the Respiratory Inhalers Market:
- AstraZeneca (UK)
- GlaxoSmithKline (UK)
- Boehringer Ingelheim (Germany)
- Novartis (Switzerland)
- Teva Pharmaceutical Industries (Israel)
- Merck & Co. (USA)
- Sanofi (France)
- Pfizer (USA)
- Mylan (USA)
- Hikma Pharmaceuticals (UK)
- Cigna (USA)
- Pulmonx Corporation (USA), and Other Active Players
Key Industry Developments in the Respiratory Inhalers Market:
- In June 2024, Boehringer Ingelheim, Pharmaceutical company has launched a new program that caps out-of-pocket costs at USD 35 per month for eligible patients using the company's inhalers. This initiative aims to make Boehringer inhalers more affordable for patients who have struggled with the current healthcare system.
- In April 2024, Teva Pharmaceutical Industries Ltd. and Launch Therapeutics, Inc. have entered into a clinical collaboration to advance the research of Teva's ICS-SABA (TEV-'248) For adult and pediatric asthma purposes, Teva's TEV-'248 may be the first Dual-Action Asthma Rescue Inhaler to combine an Inhaled Corticosteroid with a Short-Acting Beta-Agonist (ICS-SABA).
|
Respiratory Inhalers Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 34.2 Billion |
|
Forecast Period 2024-32 CAGR: |
5.9% |
Market Size in 2032: |
USD 57.32 Billion |
|
Segments Covered: |
By Type |
|
|
|
By Product |
|
||
|
By Application |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Respiratory Inhalers Market by Type
4.1 Respiratory Inhalers Market Snapshot and Growth Engine
4.2 Respiratory Inhalers Market Overview
4.3 Manually Operated
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Manually Operated: Geographic Segmentation Analysis
4.4 Digitally Operated
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Digitally Operated: Geographic Segmentation Analysis
Chapter 5: Respiratory Inhalers Market by Product
5.1 Respiratory Inhalers Market Snapshot and Growth Engine
5.2 Respiratory Inhalers Market Overview
5.3 Dry Powder Inhaler
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Dry Powder Inhaler: Geographic Segmentation Analysis
5.4 Metered Dose Inhaler
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Metered Dose Inhaler: Geographic Segmentation Analysis
5.5 Others
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Others: Geographic Segmentation Analysis
Chapter 6: Respiratory Inhalers Market by Application
6.1 Respiratory Inhalers Market Snapshot and Growth Engine
6.2 Respiratory Inhalers Market Overview
6.3 Asthma
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Asthma: Geographic Segmentation Analysis
6.4 Chronic Obstructive Pulmonary Disease COPD
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Chronic Obstructive Pulmonary Disease COPD: Geographic Segmentation Analysis
6.5 Arterial Hypertension
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Arterial Hypertension: Geographic Segmentation Analysis
6.6 Other
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Other: Geographic Segmentation Analysis
Chapter 7: Respiratory Inhalers Market by End User
7.1 Respiratory Inhalers Market Snapshot and Growth Engine
7.2 Respiratory Inhalers Market Overview
7.3 Hospitals & Clinics
7.3.1 Introduction and Market Overview
7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.3.3 Key Market Trends, Growth Factors and Opportunities
7.3.4 Hospitals & Clinics: Geographic Segmentation Analysis
7.4 Respiratory Care Center
7.4.1 Introduction and Market Overview
7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.4.3 Key Market Trends, Growth Factors and Opportunities
7.4.4 Respiratory Care Center: Geographic Segmentation Analysis
7.5 Academic and Research Institutes
7.5.1 Introduction and Market Overview
7.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.5.3 Key Market Trends, Growth Factors and Opportunities
7.5.4 Academic and Research Institutes: Geographic Segmentation Analysis
7.6 Others)
7.6.1 Introduction and Market Overview
7.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
7.6.3 Key Market Trends, Growth Factors and Opportunities
7.6.4 Others) : Geographic Segmentation Analysis
Chapter 8: Company Profiles and Competitive Analysis
8.1 Competitive Landscape
8.1.1 Competitive Benchmarking
8.1.2 Respiratory Inhalers Market Share by Manufacturer (2023)
8.1.3 Industry BCG Matrix
8.1.4 Heat Map Analysis
8.1.5 Mergers and Acquisitions
8.2 ASTRAZENECA (UK)
8.2.1 Company Overview
8.2.2 Key Executives
8.2.3 Company Snapshot
8.2.4 Role of the Company in the Market
8.2.5 Sustainability and Social Responsibility
8.2.6 Operating Business Segments
8.2.7 Product Portfolio
8.2.8 Business Performance
8.2.9 Key Strategic Moves and Recent Developments
8.2.10 SWOT Analysis
8.3 GLAXOSMITHKLINE (UK)
8.4 BOEHRINGER INGELHEIM (GERMANY)
8.5 NOVARTIS (SWITZERLAND)
8.6 TEVA PHARMACEUTICAL INDUSTRIES (ISRAEL)
8.7 MERCK & CO. (USA)
8.8 SANOFI (FRANCE)
8.9 PFIZER (USA)
8.10
8.11 OTHER ACTIVE PLAYERS
Chapter 9: Global Respiratory Inhalers Market By Region
9.1 Overview
9.2. North America Respiratory Inhalers Market
9.2.1 Key Market Trends, Growth Factors and Opportunities
9.2.2 Top Key Companies
9.2.3 Historic and Forecasted Market Size by Segments
9.2.4 Historic and Forecasted Market Size By Type
9.2.4.1 Manually Operated
9.2.4.2 Digitally Operated
9.2.5 Historic and Forecasted Market Size By Product
9.2.5.1 Dry Powder Inhaler
9.2.5.2 Metered Dose Inhaler
9.2.5.3 Others
9.2.6 Historic and Forecasted Market Size By Application
9.2.6.1 Asthma
9.2.6.2 Chronic Obstructive Pulmonary Disease COPD
9.2.6.3 Arterial Hypertension
9.2.6.4 Other
9.2.7 Historic and Forecasted Market Size By End User
9.2.7.1 Hospitals & Clinics
9.2.7.2 Respiratory Care Center
9.2.7.3 Academic and Research Institutes
9.2.7.4 Others)
9.2.8 Historic and Forecast Market Size by Country
9.2.8.1 US
9.2.8.2 Canada
9.2.8.3 Mexico
9.3. Eastern Europe Respiratory Inhalers Market
9.3.1 Key Market Trends, Growth Factors and Opportunities
9.3.2 Top Key Companies
9.3.3 Historic and Forecasted Market Size by Segments
9.3.4 Historic and Forecasted Market Size By Type
9.3.4.1 Manually Operated
9.3.4.2 Digitally Operated
9.3.5 Historic and Forecasted Market Size By Product
9.3.5.1 Dry Powder Inhaler
9.3.5.2 Metered Dose Inhaler
9.3.5.3 Others
9.3.6 Historic and Forecasted Market Size By Application
9.3.6.1 Asthma
9.3.6.2 Chronic Obstructive Pulmonary Disease COPD
9.3.6.3 Arterial Hypertension
9.3.6.4 Other
9.3.7 Historic and Forecasted Market Size By End User
9.3.7.1 Hospitals & Clinics
9.3.7.2 Respiratory Care Center
9.3.7.3 Academic and Research Institutes
9.3.7.4 Others)
9.3.8 Historic and Forecast Market Size by Country
9.3.8.1 Russia
9.3.8.2 Bulgaria
9.3.8.3 The Czech Republic
9.3.8.4 Hungary
9.3.8.5 Poland
9.3.8.6 Romania
9.3.8.7 Rest of Eastern Europe
9.4. Western Europe Respiratory Inhalers Market
9.4.1 Key Market Trends, Growth Factors and Opportunities
9.4.2 Top Key Companies
9.4.3 Historic and Forecasted Market Size by Segments
9.4.4 Historic and Forecasted Market Size By Type
9.4.4.1 Manually Operated
9.4.4.2 Digitally Operated
9.4.5 Historic and Forecasted Market Size By Product
9.4.5.1 Dry Powder Inhaler
9.4.5.2 Metered Dose Inhaler
9.4.5.3 Others
9.4.6 Historic and Forecasted Market Size By Application
9.4.6.1 Asthma
9.4.6.2 Chronic Obstructive Pulmonary Disease COPD
9.4.6.3 Arterial Hypertension
9.4.6.4 Other
9.4.7 Historic and Forecasted Market Size By End User
9.4.7.1 Hospitals & Clinics
9.4.7.2 Respiratory Care Center
9.4.7.3 Academic and Research Institutes
9.4.7.4 Others)
9.4.8 Historic and Forecast Market Size by Country
9.4.8.1 Germany
9.4.8.2 UK
9.4.8.3 France
9.4.8.4 The Netherlands
9.4.8.5 Italy
9.4.8.6 Spain
9.4.8.7 Rest of Western Europe
9.5. Asia Pacific Respiratory Inhalers Market
9.5.1 Key Market Trends, Growth Factors and Opportunities
9.5.2 Top Key Companies
9.5.3 Historic and Forecasted Market Size by Segments
9.5.4 Historic and Forecasted Market Size By Type
9.5.4.1 Manually Operated
9.5.4.2 Digitally Operated
9.5.5 Historic and Forecasted Market Size By Product
9.5.5.1 Dry Powder Inhaler
9.5.5.2 Metered Dose Inhaler
9.5.5.3 Others
9.5.6 Historic and Forecasted Market Size By Application
9.5.6.1 Asthma
9.5.6.2 Chronic Obstructive Pulmonary Disease COPD
9.5.6.3 Arterial Hypertension
9.5.6.4 Other
9.5.7 Historic and Forecasted Market Size By End User
9.5.7.1 Hospitals & Clinics
9.5.7.2 Respiratory Care Center
9.5.7.3 Academic and Research Institutes
9.5.7.4 Others)
9.5.8 Historic and Forecast Market Size by Country
9.5.8.1 China
9.5.8.2 India
9.5.8.3 Japan
9.5.8.4 South Korea
9.5.8.5 Malaysia
9.5.8.6 Thailand
9.5.8.7 Vietnam
9.5.8.8 The Philippines
9.5.8.9 Australia
9.5.8.10 New Zealand
9.5.8.11 Rest of APAC
9.6. Middle East & Africa Respiratory Inhalers Market
9.6.1 Key Market Trends, Growth Factors and Opportunities
9.6.2 Top Key Companies
9.6.3 Historic and Forecasted Market Size by Segments
9.6.4 Historic and Forecasted Market Size By Type
9.6.4.1 Manually Operated
9.6.4.2 Digitally Operated
9.6.5 Historic and Forecasted Market Size By Product
9.6.5.1 Dry Powder Inhaler
9.6.5.2 Metered Dose Inhaler
9.6.5.3 Others
9.6.6 Historic and Forecasted Market Size By Application
9.6.6.1 Asthma
9.6.6.2 Chronic Obstructive Pulmonary Disease COPD
9.6.6.3 Arterial Hypertension
9.6.6.4 Other
9.6.7 Historic and Forecasted Market Size By End User
9.6.7.1 Hospitals & Clinics
9.6.7.2 Respiratory Care Center
9.6.7.3 Academic and Research Institutes
9.6.7.4 Others)
9.6.8 Historic and Forecast Market Size by Country
9.6.8.1 Turkiye
9.6.8.2 Bahrain
9.6.8.3 Kuwait
9.6.8.4 Saudi Arabia
9.6.8.5 Qatar
9.6.8.6 UAE
9.6.8.7 Israel
9.6.8.8 South Africa
9.7. South America Respiratory Inhalers Market
9.7.1 Key Market Trends, Growth Factors and Opportunities
9.7.2 Top Key Companies
9.7.3 Historic and Forecasted Market Size by Segments
9.7.4 Historic and Forecasted Market Size By Type
9.7.4.1 Manually Operated
9.7.4.2 Digitally Operated
9.7.5 Historic and Forecasted Market Size By Product
9.7.5.1 Dry Powder Inhaler
9.7.5.2 Metered Dose Inhaler
9.7.5.3 Others
9.7.6 Historic and Forecasted Market Size By Application
9.7.6.1 Asthma
9.7.6.2 Chronic Obstructive Pulmonary Disease COPD
9.7.6.3 Arterial Hypertension
9.7.6.4 Other
9.7.7 Historic and Forecasted Market Size By End User
9.7.7.1 Hospitals & Clinics
9.7.7.2 Respiratory Care Center
9.7.7.3 Academic and Research Institutes
9.7.7.4 Others)
9.7.8 Historic and Forecast Market Size by Country
9.7.8.1 Brazil
9.7.8.2 Argentina
9.7.8.3 Rest of SA
Chapter 10 Analyst Viewpoint and Conclusion
10.1 Recommendations and Concluding Analysis
10.2 Potential Market Strategies
Chapter 11 Research Methodology
11.1 Research Process
11.2 Primary Research
11.3 Secondary Research
|
Respiratory Inhalers Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 34.2 Billion |
|
Forecast Period 2024-32 CAGR: |
5.9% |
Market Size in 2032: |
USD 57.32 Billion |
|
Segments Covered: |
By Type |
|
|
|
By Product |
|
||
|
By Application |
|
||
|
By End User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
